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Abstract
It is currently known that colorectal cancers (CRC) arise 
from 3 different pathways: the adenoma to carcinoma 
chromosomal instability pathway (50%-70%); the 
mutator “Lynch syndrome” route (3%-5%); and the 
serrated pathway (30%-35%). The World Health 
Organization has classified serrated polyps into three 
types of lesions: hyperplastic polyps (HP), sessile 
serrated adenomas/polyps (SSA/P) and traditional 
serrated adenomas (TSA), the latter two strongly 
associated with development of CRCs. HPs do not 
cause cancer and TSAs are rare. SSA/P appear to be 
the responsible precursor lesion for the development 
of cancers through the serrated pathway. Both HPs 
and SSA/Ps appear morphologically similar. SSA/P 
are difficult to detect. The margins are normally 
inconspicuous. En bloc  resection of these polyps 
can hence be troublesome. A careful examination of 
borders, submucosal injection of a dye solution (for 
larger lesions) and resection of a rim of normal tissue 
around the lesion may ensure total eradication of these 
lesions.
Key words: Colonoscopy; Sessile serrated adenoma/
polyp; Serrated lesion; Colorectal polyps; Colorectal 
cancer; Polypectomy; Image enhancing endoscopy; 
Narrow band imaging, Endocytoscopy
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Core tip: Colorectal cancers (CRC) arise from 3 path-
ways: adenoma to carcinoma; “Lynch syndrome”; and 
serrated. There are 3 types of serrated lesions namely: 
Hyperplastic Polyps, Sessile Serrated Adenomas/Polyps 
and Traditional Serrated Adenomas, the latter two are 
associated with CRC. A careful examination of borders, 
submucosal injection with dye and ensuring that a rim 
of normal tissue is removed is paramount.
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INTRODUCTION
Colorectal cancer (CRC) is a major health concern, 
especially in western countries. According to the 
American Cancer Society’s estimates, CRC accounts 
for almost 50000 deaths in the United States with 
almost 130000 new cases diagnosed in 2016. It is 
the third commonest type of cancer. Effective scree­
ning programs for identification of malignant and 
premalignant colorectal lesions are thus of utmost 
importance. In the last few decades the adenoma to 
adenocarcinoma pathway has been well recognized. 
For some time it was believed to be the only pathway 
apart from the “Lynch syndrome” route that results 
in the development of CRC. The effort to detect 
and eradicate adenoma have been the main goal in 
preventive colorectal programs, leading to improved 
outcomes. Zauber et al[1] showed that colonoscopic 
removal of adenomatous polyps led to a 53% 
reduction in mortality from CRC during the first 10 
years after polypectomy. 
It is currently believed that CRC arises from 
3 different pathways: the adenoma to carcinoma 
pathway which accounts for about 50%­70% of 
cancers; through the mutator “Lynch syndrome” route 
(3%­5%); and more recently the serrated pathway 
(30%­35%). The latter have become increasingly 
recognized as a separate route which could lead to the 
development of CRC[2]. 
This triplet division is based on the combined 
clinical­molecular characteristics of the lesions. A 
deeper understanding of the molecular pathways 
in CRC have been described by Jass in 2007[3] and 
updated by Phipps et al[4] in 2015. They described 5 
molecular subtypes and associated genetic distortions 
to describe each one. Subtypes 1, 2 and 3 are related 
to the serrated pathway. Subtypes 1 and 2 are either 
microsatellite instable (MSI)­high or microsatellite 
stable (MSS)/MSI­low cancers which have the CpG 
island methylator phenotype (CIMP) and BRAF­
mutation but are KRAS negative. The third subtype 
represents an alternative pathway which originates in 
KRAS mutation with no CIMP, BRAF or MSI association. 
Subtypes 2 and 3 have a higher association with 
mortality[4]. Subtype 4 reflects CRC arising from 
the traditional adenoma­carcinoma sequence, and 
are MSS/MSI­low, CIMP, BRAF and KRAS negative. 
Subtype 5 indicates lynch syndrome and is associated 
with high prevalence of a family history of CRC. They 
are MSI­high but CIMP, BRAF and KRAS negative. 
The serrated pathway is much less well understood. 
Systematic resection of premalignant serrated lesions 
could further improve the outcomes of CRC screening 
programs. One of the main problems with this 
protocol is the difficulty in identifying these lesions. 
Unlike adenomas, not all serrated lesions are linked 
to colorectal cancer. According to the World Health 
Organization, there are three types of serrated lesions: 
Hyperplastic polyps (HP), sessile serrated adenomas/
polyps (SSA/P) and traditional serrated adenomas (TSA). 
TSA is usually easy to identify due to its protuberant 
pine cone­shape. While SSA/P is also associated with 
cancer, HP is not and their discrimination is troublesome 
as they look morphologically similar at colonoscopy, 
even with image enhancing endoscopy (IEE) tech­
niques. Despite the adoption of numerous different 
classifications, the ability to predict HP from SSA/P 
has unfortunately been overlooked[5,6]. More recently, 
a newly proposed approach known as Workgroup 
Serrated polypS and Polyposis WASP classification has 
allowed the distinction between HP and SSA/P with 
reasonable accuracy[7]. It consists of cloud­like surface, 
indistinctive borders, irregular margins and open 
pit patterns, features described as being associated 
with SSA/P in another previous study[8]. The need to 
adequately identify SSA/P from HP arises from evidence 
supporting SSA/P as the major malignant source 
amongst serrated lesions[2,9­12].
IEE
Detecting and characterizing colorectal lesions by IEE 
has been reported in several articles[13­17] and has been 
found to have 92.7% sensitivity and 87.3% specificity 
in differentiating adenomas/adenocarcinomas from 
“non­neoplastic” lesions[18]. Differentiating serrated 
lesions, specifically SSA/P from HP is more challenging. 
The incidence of serrated lesions in the overall 
population is 5%­8% (contrasting with 30%­40% for 
adenomas), and they are more difficult to see due to 
their colour and shape[8,19,20]. Their rarity and discreet 
morphology could be why there is a longer learning 
curve compared to that for adenomas[21­24].
The evaluation of dysplasia within the SSA/Ps could 
also be of value. It has been described by Chino et 
al[25] 2016 that the evaluation of crypts and submu­
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cosal vessels with narrow band imaging (NBI) and 
magnification might be useful in evaluating dysplasia 
in SSA/P, which leads to poorer outcomes. 
Although there is certainly enthusiasm for IEE 
techniques, histopathology remains the gold standard 
for evaluating colorectal lesions. Nonetheless, improving 
technology that could be used by the endoscopist in 
real time would definitely be beneficial for serrated 
lesions as it has been for adenomas[26]. This technology 
will need to provide immediate feedback and accurately 
predict the final histopathology (Figure 1).
SSA/P AND HP DIFFERENTIATION
A conceptual way to define each serrated lesion is 
based on differences in the proliferation zones within 
the serrated crypts in each group[27]. In HP, the 
expanded proliferation zone is located at the base 
of the crypts and cells mature towards the surface 
symmetrically. In SSA/P, the proliferation zone is to 
the side of the crypts instead of the base, resulting 
in maturation of epithelial cells laterally, towards the 
surface and the base, leading to crypt base dilatation 
(pattern Ⅱ­open). Within SSA/P, the presence of 
dysplasia is usually evident and must be accompanied 
by SSA/P component adjacent to it once its his­
topathology is similar to adenomas. Unfortunately, 
this theoretical classification may be misleading. 
Confounded even by expert pathologists, the poor 
agreement for the diagnosis of villous features or high 
grade dysplasia has a 10­fold variability[28­30].
New techniques for real­time in vivo optical 
diagnosis using IEE have been developed to potentially 
predict histology and perhaps permit a more practical 
and economical approach for low­risk polyps; for 
example the “resect and discard” approach[31­34]. There 
is evidence from several original articles and meta­
analyses that in vivo optical diagnosis using either NBI 
or Fujinon intelligent chromoendoscopy would be more 
cost-effective compared to histology without significant 
changes in follow­up decision, especially for diminutive 
polyps[34­37]. The American Society for Gastrointestinal 
Endoscopy statement of 2011 (Preservation and 
Incorporation of Valuable endoscopic Innovations) 
describes the standards that new technologies have 
to achieve in order to be implemented. For the “resect 
and discard” strategy, it asks for ≥ 90% agreement 
in the assignment of post­polypectomy surveillance 
intervals when compared with decisions based on 
histopathology. With regards to the policy of leaving 
suspected rectosigmoid hyperplastic polyps measuring 
≤ 5 mm in place, a ≥ 90% negative predictive 
value for adenomatous histology is mandated[31]. Abu 
Dayyeh et al[38] on behalf of the American Societies 
for Gastrointestinal Endoscopy (ASGE) Technology 
Committee in 2015 reported in a meta­analysis that 
the diagnostic value of IEE for diminutive colorectal 
polyps achieved a pooled NPV 91% and pooled follow­
up agreement of 89%. Despite the pooled analysis 
for agreement in the assignment of surveillance 
intervals which did not reach the 90% threshold for 
NBI; experienced endoscopists were able to exceed 
this (93%) when the diagnosis was made with high 
confidence.
PREDICTORS OF MALIGNANCY AMONG 
SSA/P
The most common group of lesions are the dimi­
nutive polyps (≤ 5 mm in size), which represent 
approximately 60% of all polyps detected at primary 
screening colonoscopy. Their overall association with 
advanced pathology is low but not negligible[39,40]. 
On the contrary, Burgess et al[41] have demonstrated 
that size matters in terms of SSA/P. For every 10 mm 
increase in lesion size, the OR is 1.90 for cytological 
dysplasia. SSA/P with cytological dysplasia (SSA/P­D) 
is also associated with presence of 0­Is component of 
the Paris’ Classification (OR = 3.1), Kudo’s pit pattern 
Ⅲ, Ⅳ or Ⅴ (OR = 3.98) and increasing age (OR = 1.69 
per decade).  
Yamada et al[32] recently described the presence 
of dilated branch vessels as an aspect of SSA/Ps 
with dysplasia. Apart from their characteristics at 
chromoendoscopy and magnification[42,43], there are 
some aspects that we can use to distinguish SSA/Ps 
with and without malignancy potential. 
Endocytoscopy is an emerging modality with 
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Figure 1  Inconspicuous margins of a sessile serrated adenomas/polyps 
with and without narrow-band imaging.
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polyps of any size distributed throughout the colon. In 
these cases, the follow­up should be at 1 year[51]. The 
major problem is that these guidelines rely upon the 
assumption that the serrated lesions are detected and 
resected adequately, which is not always the case.
CONCLUSION
SSA/P is an important pre­malignant lesion that can 
easily be missed. Efforts must be made in order to 
alter the nomenclature of “non­neoplastic lesions” 
to non­adenomatous lesions as the role of serrated 
lesions in the development of colorectal cancer is now 
well established. A longer training must be pursued 
and cutting­edge IEE technologies developed and 
studied in order to diminish the miss rate for serrated 
lesions. The implementation of a “serrated polyps 
detection rate” could be implemented alongside the 
“adenoma detection rate” as a quality indicator for 
colonoscopy.
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